| Symbol | PCVX |
|---|---|
| Name | VAXCYTE, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 825 INDUSTRIAL ROAD,SUITE 300, SAN CARLOS, California, 94070, United States |
| Telephone | +1 650 837-0111 |
| Fax | — |
| — | |
| Website | https://www.vaxcyte.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001649094 |
| Description | Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Additional info from NASDAQ: |
Director PICKERING GRANT 🟡 adjusted position in 24.5K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $52.51 ($1.3M) Transaction Date: Jun 18, 2026 | Filing ID: 000010
Read moreGUGGENHIME ANDREW 🟡 adjusted position in 10.0K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $53.00 Transaction Date: Jun 18, 2026 | Filing ID: 000010
Read moreDirector Paya Carlos V 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000004
Read moreDirector BRANDICOURT OLIVIER 🟢 acquired 13.2K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000005
Read moreDirector Furey John 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000002
Read moreDirector Lee Jacks 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000002
Read moreDirector Gilbert Halley E 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000002
Read moreDirector Loxam Teri 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000009
Read moreDirector Drapeau Anne S 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000002
Read moreDirector Lukatch Heath 🟢 acquired 13.7K shares (1 derivative) of Vaxcyte, Inc. (PCVX) at $49.56 Transaction Date: Jun 15, 2026 | Filing ID: 000002
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07616934 | A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VA… | Phase1 | Group A Streptococcal Infection | Recruiting | 2026-06-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT07425392 | Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Pri… | Phase3 | Pneumococcal Vaccines | Active_Not_Recruiting | 2026-02-09 | 2027-03-01 | ClinicalTrials.gov |
| NCT07365826 | A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VA… | Phase3 | Pneumococcal Vaccines | Active_Not_Recruiting | 2026-01-12 | 2027-03-01 | ClinicalTrials.gov |
| NCT07284654 | Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Imm… | Phase3 | Pneumococcal Vaccines | Active_Not_Recruiting | 2025-12-01 | 2027-01-01 | ClinicalTrials.gov |
| NCT06720038 | A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VA… | Phase2 | Pneumococcal Vaccines | Active_Not_Recruiting | 2024-11-25 | 2027-12-01 | ClinicalTrials.gov |
| NCT06151288 | Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conj… | Phase1 | Pneumococcal Vaccines | Completed | 2023-11-08 | 2024-07-17 | ClinicalTrials.gov |
| NCT05844423 | Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate … | Phase2 | Pneumococcal Vaccines | Completed | 2023-03-29 | 2025-08-25 | ClinicalTrials.gov |
| NCT05297578 | Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conj… | Phase2 | Pneumococcal Vaccines | Completed | 2022-06-15 | 2023-02-15 | ClinicalTrials.gov |
| NCT05266456 | Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conj… | Phase1 | Pneumococcal Vaccines | Completed | 2022-02-22 | 2023-01-10 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| VAX-A1 High | Other | Phase PHASE1 | Group A Streptococcal Infection | RECRUITING | NCT07616934 |
| VAX-A1 Mid | Other | Phase PHASE1 | Group A Streptococcal Infection | RECRUITING | NCT07616934 |
| VAX-A1 Low | Other | Phase PHASE1 | Group A Streptococcal Infection | RECRUITING | NCT07616934 |
| Placebo | Other | Phase PHASE1 | Group A Streptococcal Infection | RECRUITING | NCT07616934 |
| VAX-A1 High | Other | Phase PHASE1 | Group A Streptococcal Infection | NOT_YET_RECRUITING | NCT07616934 |
| VAX-A1 Mid | Other | Phase PHASE1 | Group A Streptococcal Infection | NOT_YET_RECRUITING | NCT07616934 |
| VAX-A1 Low | Other | Phase PHASE1 | Group A Streptococcal Infection | NOT_YET_RECRUITING | NCT07616934 |
| Placebo | Other | Phase PHASE1 | Group A Streptococcal Infection | NOT_YET_RECRUITING | NCT07616934 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07425392 |
| 20 valent pneumococcal conjugate vaccine | Other | Phase PHASE1 | Pneumococcal Vaccines | COMPLETED | NCT06151288 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE1 | Pneumococcal Vaccines | COMPLETED | NCT06151288 |
| 0.5 ml dose of 2.2/4.4 mcg VAX-24 | Other | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 0.5 ml dose of 2.2 mcg VAX-24 | Other | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 0.5 ml dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 0.5 ml dose of 1.1 mcg VAX-24 | Other | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 20 valent pneumococcal conjugate vaccine | Other | Phase PHASE1 | Pneumococcal Vaccines | COMPLETED | NCT05266456 |
| 24 valent pneumococcal conjugate vaccine | Other | Phase PHASE1 | Pneumococcal Vaccines | COMPLETED | NCT05266456 |
| Pneumococcal 20-valent Conjugate Vaccine | Other | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05297578 |
| 24-Valent Pneumococcal Conjugate Vaccine | Other | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05297578 |
| 0.5 mL of the High-PFS dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | Other | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | RECRUITING | NCT07425392 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | RECRUITING | NCT07425392 |
| Placebo | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| PCV21 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 31 valent pneumococcal conjugate vaccine | Other | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| Placebo | BIOLOGICAL | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| Seasonal Influenza Vaccine (SIV) (Flublok) | BIOLOGICAL | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07365826 |
| 31-valent pneumococcal conjugate vaccine | BIOLOGICAL | Phase PHASE3 | Pneumococcal Vaccines | RECRUITING | NCT07425392 |
| PCV21 | BIOLOGICAL | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| PCV20 | BIOLOGICAL | Phase PHASE3 | Pneumococcal Vaccines | RECRUITING | NCT07425392 |
| 0.5 mL of the High-PFS dose VAX-31 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL dose of PCV20 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the high dose VAX-31 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the mid dose VAX-31 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 0.5 mL of the low dose VAX-31 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT06720038 |
| 31 valent pneumococcal conjugate vaccine | BIOLOGICAL | Phase PHASE3 | Pneumococcal Vaccines | ACTIVE_NOT_RECRUITING | NCT07284654 |
| 0.5 ml dose of 2.2/4.4 mcg VAX-24 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 0.5 ml dose of 2.2 mcg VAX-24 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 0.5 ml dose of PCV20 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| 0.5 ml dose of 1.1 mcg VAX-24 | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05844423 |
| Pneumococcal 20-valent Conjugate Vaccine | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05297578 |
| 24-Valent Pneumococcal Conjugate Vaccine | BIOLOGICAL | Phase PHASE2 | Pneumococcal Vaccines | COMPLETED | NCT05297578 |
| 20 valent pneumococcal conjugate vaccine | BIOLOGICAL | Phase PHASE1 | Pneumococcal Vaccines | COMPLETED | NCT06151288 |
| 24 valent pneumococcal conjugate vaccine | BIOLOGICAL | Phase PHASE1 | Pneumococcal Vaccines | COMPLETED | NCT05266456 |